Summary presentation by Thayer, Ann
The twelfth annual meeting of the National Agricultural Biotechnology Council
(NABC) brought together a collection of distinguished speakers on diverse
subjects, with many different points of view espoused. The NABC strives to
obtain a balance of opinions, and fosters communication on very challenging
and often controversial topics. Its workshops are designed to serve as resources
for broad-based discussion and policy-making.
The goal of this summary is not to give a chronological overview of the
conference, but to search for common threads and possible disconnects among
the ideas that were presented. To that end, I will seek answers to several simple
questions — who, what, when, where, why, and how? — as they pertain to a
biobased economy.
Speakers articulated many instructive and challenging ideas as they described
their visions of the biobased economy. From examination of the definition of
what the biobased economy is, several fundamental elements were outlined,
including:
• raw materials from renewable resources
• highly productive agricultural systems both for food and industrial needs
• integrated, multidisciplinary approaches to R&D that combine agriculture,
engineering, health, information technology, and other technologies and
disciplines
• eventually 50 percent of fuels and more than 90 percent of organics and
materials will be biobased
• beneficial effects on the environment, energy security, and rural econo-
mies.
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Having defined the elements of a biobased economy, participants presented
their views on its importance, anticipating the following benefits:
• sustainable production of needed materials, food, and energy
• revitalization of agriculture and better use of resources
• decreased dependence on foreign, and diminishing supplies of , oil-based
raw materials
• political and economic self-sufficiency and security
• functionally superior, value-added products
• improved impact on global climate and the environment
• need to support and feed a growing world population.
Views were varied on when a biobased economy would take hold and become
a reality. The question of time-scale generated the greatest discrepancy of
viewpoints. Government representatives, largely from the USDA and DOE,
cited goals and time frames established within President Clinton’s Executive
Order 13134, and the National Research Council report, “Biobased Industrial
Products: Priorities for Research and Commercialization,” issued in 1999. Thus,
most major goals for a biobased economy are targeted for the years 2010, 2020,
and 2090. There was little, if any, discussion of how these time-frames were
derived and whether they are realistic.
Instead, most discussion focused on the current status of developments.
While no one would claim that a biobased economy exists today, these
discussions provided information on progress, and clues as to how fast we
are advancing toward it. An apparent consensus existed that a technology-base
is forming, that governmental forces are encouraging advances, and that some
early developments are expected in terms of new commercialized products.
For many, these ideas were expressed by the frequently used phrase, “the
stars are aligning.” Government policy and agency efforts are promoting the
development of a biobased economy. A clear response from academia is evident
in the level of enthusiasm for creating new biobased technologies and the
number of research projects undertaken. However, it is uncertain how much
of the recent governmental push for a biobased economy hinged on the tripling
of oil prices during 1999.
In contrast to the consensus, plenary speaker Ralph Nader offered a
conflicting view. He described NABC’s own position document on the biobased
economy as “too optimistic, too self-assured, and too futuristically determined”
that a biobased economy will become a reality. Nader suggested that a biobased
economy will exist only as a promise as long as questions remain regarding the
safety of some related technologies, particularly genetic engineering, and as
long as power and decision-making lie within corporations.
Nader also stated that the biomaterial movement “depends on whether it is
driven by a for-profit corporate structure or by arms-length government/
university research, a free exchange of scientific information between scientists
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and a different set of priorities.” Lois Levitan also raised serious and thought-
provoking questions about whether a biobased economy is even possible, much
less sustainable.
On a more optimistic note, Jerry Caulder stated his belief that success is
already apparent. As an illustration of success in creating biobased materials
and products, he noted that “we can and are doing it... in not just producing
proteins, but in controlling metabolic pathways.”
With few industrial participants, the corporate/industrial view of a biobased
economy was limited. DuPont, one of the most active and openly committed
companies developing biomaterials, provided insight into its development
and commercialization of 3GT, a new form of polyester. However, DuPont’s
commitment to the creation and development of biobased materials is a near
exception among the dozens of chemical, oil and gas, and other companies
with products based on petroleum feedstocks.
Nader suggested that the creation of a biobased economy could not take
place under the current industrial and corporate structure. A contrasting view
argued that corporations will be critical to the creation of biobased materials,
as it is they who will make the investment to develop, commercialize, and
market products. A greater industry presence at NABC meetings will be critical
to expanding the discussion of the economic viability and industrial support
needed to develop and further a biobased economy.
Obviously, there remain many issues, questions, and challenges to creating
a biobased economy. This is a large part of the “how” question and involves
not just the scientific and technological how, but the economic, political, and
societal hows, along with questions of who (the roles various parties will play),
where (what developments will occur first and in what markets), and when
(how quickly technology will achieve the desired goals).
Some of the issues and challenges that still must be addressed are:
• moving technologies beyond their early stages of development
• ability and incentive to create new and desired products cost effectively
• modifications in processing and production systems including the creation
of new supporting infrastructure
• integration with existing fossil-fuel approaches and infrastructure
• displacements and transitions on many fronts, most notably agriculture
• understanding environmental, societal, policy, and economic impacts
• opposition to new technology and products derived from that technology.
Many other questions were raised and challenges made. Among these were
questions on intellectual property and its concentration in limited hands; on
the impact of consolidation in industry and agriculture; on research funding
and support; on the responsibility for demonstrating that technology is safe,
advantageous or value-creating; and on the responsibility for educating the
public and ensuring science-based decision-making.
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In creating biobased products and a biobased economy, it is important to
keep in mind the role that industry and market dynamics will play. Companies
likely will evaluate biobased technologies that yield cost-effective, competitive,
and successful products. Business sustainability is an important long-term
issue, but companies are under many short-term pressures to create returns
on their investments.
Only a few, although prominent, companies such as Dow Chemical and
DuPont are viewing the combination of chemistry and biology as an opportu-
nity for growth and new products in mature businesses. However, these
companies tend to be exceptions and greater industrial “buy-in” and participa-
tion will most likely be needed.
Moving beyond niche markets with major product successes will do much
to validate the acceptance of biobased technologies among current industrial
players. Product commercialization milestones may also serve to convince
shareholders and Wall Street of the viability of “biobased-business plans.”
On the horizon are Dow’s commercialization of polylactic acid and DuPont’s
new polyester, 3GT. Polylactic acid is produced from corn-based starting
materials, and one of the 3GT intermediates, 1,3-propanediol, can be produced
via biocatalysis.
Industrial-scale production of biobased materials still faces many challenges
in increasing yields and reducing costs. There are cost-related issues associated
with raw-material production, transportation, processing, and operations. Many
of these must still be addressed to gain and maintain industrial interest and
long-term investments.
Pressures from Wall Street and shareholders can be serious constraints to a
corporation’s ability to maintain a long-term vision. Government is often no
better. Currently, the federal government is backing biobased initiatives, which
may change at any time for political, economic, or other reasons. Several
speakers addressed this point with the message, “We’ve been here before.”
In addition, this is an election year with new initiatives being set, often for
political reasons, and a new administration on the horizon with its own agenda.
Universities may be best suited to maintain the long-term vision and create
the basic knowledge needed for technological progress. But visions need to be
periodically reviewed in light of marketplace, political, and other realities.
In order for biobased products to succeed in the marketplace, there is much
to be said for market-pull driving their creation, rather than technology
pushing unwanted products on consumers. For example, Dow emphasizes the
functionality of polylactic acid, at least as much as the polymer’s biodegrad-
ability. Several years ago, a push to create biodegradable polymers was met with
limited enthusiasm from the marketplace. Dow’s development of polylactic
acid strives to address potential customer needs rather than just have a
biological origin.
Although at least one speaker suggested that technology has gotten ahead
of the science, arguments can be made also that technology is ahead of the
marketplace. Some argue that the initial products of agricultural biotechnology
were designed only to leverage and perpetuate existing businesses. Whether
this is true or not, companies do admit to a myopic view of their initial
customers — namely, the farmers — and grossly underestimated consumer
reaction and its impact on the agricultural value chain. Assumptions, if any,
made about consumer reaction and acceptance of the first genetically
engineered insect-resistant and herbicide-tolerant crops may have contributed
to major miscalculations in marketing strategy.
Biotechnology has been more readily accepted where there was clear benefit
to consumers — for example, in biopharmaceuticals. In the agricultural arena,
producers now are working to develop “second-generation” products that many
hope will alter consumer sentiment, including food and agricultural products
with improved nutritional or health profiles. Consumer acceptance may be an
important factor in the development of products that, although not containing
genetically modified components, are produced through genetic engineering.
There already is anecdotal evidence of protests against fibers from genetically
engineered cotton, and questions are being raised about recombinant industrial
enzymes.
To achieve the goal of creating a biobased economy, at least four major
groups will be involved, each of which has its own role and array of contribu-
tions. The groups and their areas of impact and expertise, as envisioned by the
participants, are listed below.
• Government: policy and regulation, create goals and road maps, economic
and risk assessment, build on existing networks, technology creation, and
funding and support.
• Academia: basic research, education, and integration and partnerships.
• Industry: product development, investment, commercialization, and
marketing.
• Farmers: raw-material supply, creation of new business opportunities and
partnerships.
In summary, the NABC represents a high level of enthusiasm for a vision of
a biobased economy that promises the following:
• great potential and opportunities for expansion beyond food, feed, and
fiber to include industrial products and energy production
• the future for agriculture
• cooperative interaction of government, academia, industry, and the public
• integrated approach through R&D and business partnerships
• improved quality of life, environment, health, security, and economics.
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